10/12/2014Chinese Media Challenges the CMA over Sponsorships

10/11/2014Financial-related Company News in Brief

10/11/2014SMEI: Chinese Pharma Output Value Estimated to Grow Nearly 20% in 2014

10/11/2014Data Snapshot: Chinese Pharma Performance in H1/2014

10/11/2014China's Western Medicine Foreign Trade Maintains Steady Growth in H1/2...

10/10/2014CSL Expands Albumin Production to Meet Rising Chinese and Global Deman...

10/8/2014Success Story: CleveXel's Collaboration with Guilin Pharma for Develop...

10/8/2014Lee's Licenses Greater China Rights of mAb Drug from Sorrento

10/7/2014Financial-related Company News in Brief

10/7/2014Recent Executive Moves

10/2/2014Alliance Boots Approved by CSRC to Acquire 12% of Nanjing Pharma

10/2/2014WuXi PharmaTech Acquires US-based CRO XenoBiotic

10/2/2014Recent Executive Moves

9/29/2014Ten Potential Risk Trends for Chinese Pharma in 2015

9/29/2014Hunan to Require Zero Drug Sales Margins in All County Level Public Ho...

9/26/2014Financial-related Company News in Brief

9/26/2014EFPIA Delegation Visits China to Show Commitment

9/26/2014Beijing Formulates New Policies to "Separate Medical Service from...

9/25/2014Epirus, Livzon Mabpharm Partnerhip Deal for Biosimilars

9/24/2014Lessons from GlaxoSmithKline's Record $492 Million Bribery Fine in Chi...

9/24/2014Jointown's Haoyaoshi Enters O2O Partnership with Chunyu Yisheng

9/24/2014Recent Executive Moves

9/23/2014Merck Serono, CSCO Co-founds Oncology Research Fund

9/23/2014Chengdu to Remove Drug Sales Margins in County Level Public Hospitals

9/22/2014IMS: Chinese Hospital Drug Sales Growth Slowed in Q1/2014

9/21/2014Recent Executive Moves

9/19/2014Financial-related Company News in Brief

9/19/2014Executive Moves

9/18/2014Spectrum Pharma Licenses China Rights of Oncology Drugs to CASI Pharma

9/17/20143SBio Licenses China Rights of Anticancer from JenKem

Page:259/376 Total number of articles:11263: [First][<<] [257] [258] [259] [260] [261] [>>] [End]